RMG Acquisition III, the third blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, raised $420 million by offering 42 million units at $10. Each unit consists of one share of common stock and one-fifth of a...read more
RMG Acquisition III, a third blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, raised the proposed deal size for its upcoming IPO on Tuesday.
The New York, NY-based company now plans to raise $420 million...read more
In a staggering start to 2021, two biotechs and 28 SPACs raised over $7.1 billion in the first week of the new year. Activity should remain high as new filings continued to flood the IPO pipeline. Chinese cancer biotech ...read more
RMG Acquisition III, the third blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, filed on Monday with the SEC to raise up to $350 million in an initial public offering. The New York, NY-based company...read more
Carpenter and Mancini's third SPAC RMG Acquisition III prices $420 million IPO
RMG Acquisition III, the third blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, raised $420 million by offering 42 million units at $10. Each unit consists of one share of common stock and one-fifth of a...read more
Carpenter and Mancini's SPAC RMG Acquisition III raises deal size by 20% ahead of $420 million IPO
RMG Acquisition III, a third blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, raised the proposed deal size for its upcoming IPO on Tuesday. The New York, NY-based company now plans to raise $420 million...read more
US IPO Weekly Recap: The new year kicks off with 2 biotech IPOs and a tidal wave of SPACs
In a staggering start to 2021, two biotechs and 28 SPACs raised over $7.1 billion in the first week of the new year. Activity should remain high as new filings continued to flood the IPO pipeline. Chinese cancer biotech ...read more
Carpenter and Mancini's SPAC RMG Acquisition III files for a $350 million IPO
RMG Acquisition III, the third blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, filed on Monday with the SEC to raise up to $350 million in an initial public offering. The New York, NY-based company...read more